Evaluating Use of Empagliflozin for Diabetes Management in Veterans With Chronic Kidney DiseaseNovember 6, 2024DiabetesNephrology
VHA Support for Home Health Agency Staff and Patients During Natural DisastersNovember 1, 2024GeriatricsHealth Policy
The Impact of a Metformin Recall on Patient Hemoglobin A1c Levels at a VA NetworkOctober 30, 2024Diabetes
Continuous Glucose Monitoring vs Fingerstick Monitoring for Hemoglobin A1c Control in VeteransOctober 29, 2024Diabetes
Short Interval Repeat Colonoscopy After Inadequate Bowel Preparation Is Low Among VeteransSeptember 18, 2024OncologyColon and Rectal
Establishing a Just Culture: Implications for the Veterans Health Administration Journey to High ReliabilitySeptember 18, 2024Health Policy
VA Cancer Clinical Trials as a Strategy for Increasing Accrual of Racial and Ethnic Underrepresented GroupsSeptember 12, 2024OncologyCancer
CDK7 Inhibition in Patient-Derived Organoid Modeling of Biliary Tract CancersSeptember 12, 2024Oncology
Carboplatin as a Radiosensitizing Agent in Locally Advanced Head and Neck Cancer: Friendly to an Older Veteran PopulationSeptember 12, 2024Oncology
Variation in Cardiovascular Risk Assessment Status in Patients Receiving Oral Anti-Cancer Therapies: A Focus on Equity throughout VISN (Veteran Integrated Service Network) 12September 11, 2024OncologyCancerCardiology
Developing a Cancer Rehabilitation Program—Improving Access to Ancillary Services to Mitigate the Impact of Cancer and its Treatments for Veterans Diagnosed With CancerSeptember 11, 2024OncologyCancer
“It Takes a Village”: Benefits and Challenges of Navigating Cancer Care with the Pacific Community and the Veterans Health AdministrationSeptember 10, 2024OncologyCancer
Influence of Patient Demographics and Facility Type on Overall Survival in Sezary SyndromeSeptember 10, 2024Oncology
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple MyelomaSeptember 10, 2024OncologyMultiple MyelomaHematologic Malignancies
